Alger Health Sciences Fund Class C (AHSCX)
| Fund Assets | 66.90M |
| Expense Ratio | 1.96% |
| Min. Investment | $1,000 |
| Turnover | 289.28% |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | n/a |
| Previous Close | 15.65 |
| YTD Return | 16.33% |
| 1-Year Return | 44.23% |
| 5-Year Return | -12.50% |
| 52-Week Low | 11.09 |
| 52-Week High | 16.24 |
| Beta (5Y) | 0.76 |
| Holdings | 60 |
| Inception Date | May 1, 2002 |
About AHSCX
The Alger Health Sciences Fund Class C is a mutual fund focused on investing in companies within the health sciences sector. Its primary objective is capital preservation and appreciation, achieved by building a portfolio concentrated mostly in U.S.-based healthcare firms. The fund employs a large blend investment style, targeting both growth and value opportunities across the healthcare industry, including medical technology, biotechnology, pharmaceuticals, medical devices, and related sub-sectors. The top holdings account for a significant portion of the fund's assets, featuring major names such as UnitedHealth Group, Intuitive Surgical, and Boston Scientific, reflecting a strategy centered on leading health science innovators. With a relatively high turnover rate and above-average expense ratio, the fund is managed with an active approach to capture emerging opportunities within the dynamic healthcare landscape. Overall, it serves investors seeking exposure to the expanding and evolving health sciences sector through a professionally managed, diversified portfolio.
Performance
AHSCX had a total return of 44.23% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.69%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
35.38% of assets| Name | Symbol | Weight |
|---|---|---|
| Teva Pharmaceutical Industries Limited | TEVA | 4.58% |
| IMPULSE DYNAMICS IRELAND | n/a | 4.57% |
| Forte Biosciences, Inc. | FBRX | 4.28% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 4.04% |
| Welltower Inc. | WELL | 3.23% |
| Cardinal Health, Inc. | CAH | 3.22% |
| Johnson & Johnson | JNJ | 2.99% |
| Twist Bioscience Corporation | TWST | 2.93% |
| Merck & Co., Inc. | MRK | 2.88% |
| Nektar Therapeutics | NKTR | 2.66% |